CRO Services
When protein complexity becomes a bottleneck, our engineered ExpreS2 platform delivers.
Fast timelines, high yields, and native-like folding & glycosylation.
ExpreS2ion has successfully developed and produced over 500 different hard-to-express proteins with a success rate above 90 percent.
Challenges We Solve
How We Help
Why Trust Us
- Difficulty expressing complex, disulfide-rich, or heavily glycosylated proteins
- Low or inconsistent yields from CHO, HEK, or E. coli systems
- Misfolding or instability resulting in inactive proteins
- Long timelines and delays in early-stage development
- Batch variability in research-grade protein supply
- Need for a virus-free, scalable expression system suitable for clinical transition and/or production
- ExpreS2™ Platform: High success rate with >500 proteins expressed
- Native-like Protein Quality: Proper folding and eukaryotic glycosylation
- No Baculovirus Required: Simplifies workflows and reduces regulatory hurdles
- Scalable Production: From mg-scale feasibility to g-scale preclinical batches
- Rapid Timelines: Feasibility studies completed in weeks
- GlycoX-S2™: Glyco-engineered variants available for enhanced immunogenicity or function
- Flexible Engagement: Fee-for-service, project-based campaigns, and licensing options
- Clinically Validated Platform: Used in ten clinical-stage studies, up to and including meeting a clinical Phase 3 primary endpoint
- Proven Track Record: 15+ years of experience and >90% expression success
- Approved Product: ExpreS2™-produced antigen received full regulatory approval post-Phase III
- Trusted by Industry Leaders: Collaborations across pharma, biotech, and diagnostics
- Smooth Tech Transfer: Proven handover to GMP CDMOs
- Scientifically Grounded: Built on academic expertise, validated by peer-reviewed research
If you want to know more, please contact: info@expres2ionbio.com or +45 2222 1019